Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA.

Published

Journal Article (Review)

Staphylococcus aureus bacteremia (SAB) is an urgent medical problem due to its growing frequency and its poor associated outcome. As healthcare delivery increasingly involves invasive procedures and implantable devices, the number of patients at risk for SAB and its complications is likely to grow. Compounding this problem is the growing prevalence of methicillin-resistant S. aureus (MRSA) and the dwindling efficacy of vancomycin, long the treatment of choice for this pathogen. Despite the recent availability of several new antibiotics for S. aureus, new strategies for treatment and prevention are required for this serious, common cause of human infection.

Full Text

Duke Authors

Cited Authors

  • Rasmussen, RV; Fowler, VG; Skov, R; Bruun, NE

Published Date

  • January 2011

Published In

Volume / Issue

  • 6 / 1

Start / End Page

  • 43 - 56

PubMed ID

  • 21162635

Pubmed Central ID

  • 21162635

Electronic International Standard Serial Number (EISSN)

  • 1746-0921

Digital Object Identifier (DOI)

  • 10.2217/fmb.10.155

Language

  • eng

Conference Location

  • England